Metraipolis › archive › dc_3fb1c9be25cf

Progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseases — Europe PMC PMID:40873547

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40873547
DOI
10.3389/fphar.2025.1628602
License (as archived)
solo-consultazione
Archived
2026-11-10T17:06:13.031Z
SHA-256 of the archived text
ca81b5d00cf9476b563d8d3d731d81385e088f4601d08be3a01b18a2ef56a995
Stable URL of this page
https://metraipolis.com/documento/dc_3fb1c9be25cf

How to cite

Progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseases — Europe PMC PMID:40873547 — Europe PMC (en), https://europepmc.org/article/MED/40873547 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3fb1c9be25cf (Metraipolis archive dc_3fb1c9be25cf, sha256 ca81b5d00cf9476b563d8d3d731d81385e088f4601d08be3a01b18a2ef56a995)
BibTeX
@misc{dc3fb1c9be25cf,
  title = {Progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseases — Europe PMC PMID:40873547},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40873547},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3fb1c9be25cf; sha256 ca81b5d00cf9476b563d8d3d731d81385e088f4601d08be3a01b18a2ef56a995},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40873547. Agents can read the archived copy with the MCP tool read_document.